The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cryotherapy market reached a value of US$ XX Billion in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Cryotherapy refers to a non-invasive technique used for alleviating pain and treating orthopedic injuries. It involves freezing and removing abnormal skin growth, such as warts and tags, and localized tumors for the treatment of prostate, cervical and liver cancer. It utilizes liquid nitrogen, liquid nitrous oxide and compressed argon gas for cryoablation and cryosurgery. Cryotherapy also aids in the treatment of rheumatoid arthritis, anxiety, asthma, migraine and muscle soreness. It is commonly preferred by individuals trying to reduce body weight by increasing metabolism and maintaining high body temperatures. In comparison to the traditionally used therapeutic procedures, cryotherapy promotes faster recovery, has minimal risks of affecting non-targeted areas and is widely used for the treatment of oncological, dermatological and cardiological disorders.
The increasing prevalence of chronic medical disorders across the globe is one of the key factors driving the market growth. Whole-body cryotherapy (WBC) is widely used for the treatment of various health conditions, malignant and benign tumors, tissue damages or lesions and sports injuries. Moreover, the rising preference for minimally and non-invasive therapeutic procedures among patients and healthcare providers is providing a thrust to the market growth. Various technological advancements, such as the development of cryochambers and cryo-saunas for the treatment of inflammation, rheumatoid arthritis and chronic pain, are acting as other growth-inducing factors. In line with this, the increasing utilization of thin and supercooled probes and cryoablation needles with helium-free thaw capabilities is also contributing to the growth of the market. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cryotherapy market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Brymill Cryogenic Systems, CooperSurgical Inc., Cortex Technology, CryoConcepts LP, Erbe Elektromedizin GmbH, Kriosystem-Care Sp. z o.o., Medtronic plc, METRUM CRYOFLEX Sp. z o.o. Sp. k., Pacira BioSciences Inc., US Cryotherapy and Zimmer MedizinSysteme GmbH.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Boston Scientific Corporation, Brymill Cryogenic Systems, CooperSurgical Inc., Cortex Technology, CryoConcepts LP, Erbe Elektromedizin GmbH, Kriosystem-Care Sp. z o.o., Medtronic plc, METRUM CRYOFLEX Sp. z o.o. Sp. k., Pacira BioSciences Inc., US Cryotherapy and Zimmer MedizinSysteme GmbH.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at